Showing results (31-40 of 162) with videos related to

Sort By:
Pageof 17
Gynecologic Oncology|July 7, 2009
Plasma calprotectin concentrations in women with endometrial carcinomaHannah Ni Bhriain, Jone Trovik, Elisabeth Wik, et al.
International Journal of Oncology|January 19, 2008
HER-2/neu expression is associated with high tumor cell proliferation and aggressive phenotype in a population based patient series of endometrial carcinomasIngeborg B Engelsen, Ingunn M Stefansson, Rameen Beroukhim, et al.
Scientific Reports|March 29, 2019
Influence of p53 Isoform Expression on Survival in High-Grade Serous Ovarian CancersKatharina Bischof, Stian Knappskog, Sigrun M Hjelle, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|May 28, 2011
Elevated plasma growth differentiation factor-15 correlates with lymph node metastases and poor survival in endometrial cancerAnne Cathrine Staff, Jone Trovik, Ane Gerda Zahl Eriksson, et al.
Gynecologic Oncology|October 8, 2003
Molecular assessment of depth of myometrial invasion in stage I endometrial cancer: a model based on K-ras mutation analysisFarhad Alexander-Sefre, Helga B Salvesen, Andy Ryan, et al.
Cancer Immunology, Immunotherapy : CII|January 24, 2006
Ri antibodies in patients with breast, ovarian or small cell lung cancer determined by a sensitive immunoprecipitation techniqueAnette Knudsen, Sissel E Monstad, Anne Dørum, et al.
International Journal of Cancer|February 22, 2005
Low frequency of BRAF and CDKN2A mutations in endometrial cancerHelga B Salvesen, Rajiv Kumar, Ingunn Stefansson, et al.
Pageof 17